Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 15/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | SCN4A | P35499 | 1/20 | 0.43 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.43 |
| ▸ | P2RX1 | P51575 | 6/20 | 0.41 |
| ▸ | P2RX3 | P56373 | 6/20 | 0.41 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.37 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3375661 | 1.00 | P2RX4 (0.44) | P2RX4LMNATSHRMAPK1SCN4A | |
| SCHEMBL3241414 | 0.86 | P2RX4 (0.42) | P2RX4LMNATSHRMAPK1SCN4A | |
| SCHEMBL8705933 | 0.84 | P2RX4 (0.57) | P2RX4LMNATSHRMAPK1SCN4A | |
| Indole SCHEMBL28214491 | 0.84 | TRPA1 (0.45) | P2RX4LMNATSHRMAPK1SCN4A | |
| SCHEMBL1477941 | 0.84 | NOTUM (0.46) | P2RX4LMNATSHRMAPK1SCN4A | |
| SCHEMBL1286806 | 0.84 | LMNA (0.55) | P2RX4LMNATSHRMAPK1SCN4A | |
| Quinoline SCHEMBL28157604 | 0.83 | ALDH1A1 (0.44) | P2RX4LMNAMAPK1MEN1KMT2A | |
| Isoquinoline SCHEMBL28075529 | 0.83 | P2RX4 (0.38) | P2RX4LMNATSHRMAPK1SCN4A | |
| SCHEMBL7832555 | 0.82 | P2RX4 (0.42) | P2RX4LMNATSHRMAPK1SCN4A | |
| Hydrochloric Acid SCHEMBL28145471 | 0.82 | LMNA (0.53) | P2RX4LMNATSHRMAPK1SCN4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113072553-B | Preparation method and application of dehydrobufotenine | 河北工业大学 | 2022-02-25 | — | — | CN | claimed |
| EP-4536656-A1 | BICYCLIC-SUBSTITUTED GLUTARIMIDE CEREBLON BINDERS | C4 Therapeutics, Inc. (US) | 2025-04-16 | — | — | EP | disclosed |
| CN-114702544-B | Amino steroid compound, and preparation method and application thereof | 湖南科益新生物医药有限公司 | 2024-01-30 | — | — | CN | disclosed |
| WO-2024006379-A1 | METHODS AND COMPOUNDS FOR INHIBITING MKK7 ENZYMES | AXONIS THERAPEUTICS, INC. (US) | 2024-01-04 | — | — | WO | disclosed |
| WO-2023239750-A1 | BICYCLIC-SUBSTITUTED GLUTARIMIDE CEREBLON BINDERS | C4 THERAPEUTICS, INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| EP-4243804-A1 | SUBSTANCES FOR TREATMENT OF HYPERURICAEMIA | ScandiBio Therapeutics AB (SE) | 2023-09-20 | — | — | EP | disclosed |
| EP-4213831-A1 | SUPPLEMENT FOR TREATMENT OF CORONAVIRUS INFECTION | ScandiBio Therapeutics AB (SE) | 2023-07-26 | — | — | EP | disclosed |
| EP-4192444-A1 | AMINOACIDS FOR TREATMENT OF NEUROLOGICAL DISORDERS | ScandiBio Therapeutics AB (SE) | 2023-06-14 | — | — | EP | disclosed |
| CN-114041471-B | Application of dehydrobufotenine | 河北工业大学 | 2023-03-31 | — | — | CN | disclosed |
| CN-114702544-A | Amino steroid compound and preparation method and application thereof | 上海醇健实业发展有限公司 | 2022-07-05 | — | — | CN | disclosed |
| WO-2022123530-A1 | BORONIC ACID COMPOUND | 주식회사 엘지화학 | 2022-06-16 | — | — | WO | disclosed |
| WO-2022101501-A1 | SUBSTANCES FOR TREATMENT OF HYPERURICAEMIA | SCANDIBIO THERAPEUTICS AB (SE) | 2022-05-19 | — | — | WO | disclosed |
| WO-2022063303-A1 | A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF | 石药集团中奇制药技术（石家庄）有限公司 | 2022-03-31 | — | — | WO | disclosed |
| WO-2022058026-A1 | SUPPLEMENT FOR TREATMENT OF CORONAVIRUS INFECTION | SCANDIBIO THERAPEUTICS AB (SE) | 2022-03-24 | — | — | WO | disclosed |
| CN-113072553-B | Preparation method and application of dehydrobufotenine | 河北工业大学 | 2022-02-25 | — | — | CN | disclosed |
| CN-114044800-A | Aryl, heteroaryl and heterocyclic compounds for the treatment of medical disorders | 艾其林医药公司 | 2022-02-15 | — | — | CN | disclosed |
| CN-114041471-A | Application of dehydrobufotenine | 河北工业大学 | 2022-02-15 | — | — | CN | disclosed |
| WO-2022028678-A1 | SUBSTANCES FOR TREATMENT OF NEUROLOGICAL DISORDERS | SCANDIBIO THERAPEUTICS AB (SE) | 2022-02-10 | — | — | WO | disclosed |
| WO-2022029184-A1 | AMINOACIDS FOR TREATMENT OF NEUROLOGICAL DISORDERS | SCANDIBIO THERAPEUTICS AB (SE) | 2022-02-10 | — | — | WO | disclosed |